Saturday 17 October 2026
Export MCTA’s income statement to Excel — free account
Charming Medical Limited
MCTA Healthcare Medical Care Facilities
Charming Medical Limited’s revenue for fiscal 2026 (year ended March 2026) was $4.8 million, down 22.7% from fiscal 2025.
29.36
0.00
0.00%
Follow MCTA
| Mar '26 | Mar '25 | Mar '24 | |
|---|---|---|---|
Piotroski F-Score |
2 | — | — |
Altman Z-Score |
61.64 | — | — |
Altman Z″-Score (non-manufacturers) |
3.73 | (0.11) | (2.50) |
Beneish M-Score |
(2.49) | (1.97) | — |
P/B ratio |
0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 | 0.00 |
Quick Ratio |
1.56 | 0.64 | 0.57 |
Current Ratio |
1.89 | 0.68 | 0.62 |
Net Debt/EBITDA |
(34.00) | (1.42) | (1.17) |
Debt/Assets |
1.88% | 7.74% | 9.45% |
Debt/Equity |
0.04 | 8.42 | (0.40) |
Asset Turnover |
0.63 | 1.22 | 0.00 |
Operating CF/Net income |
53.80 | 0.36 | 0.38 |
Capex/Depreciation |
(1.43) | (1.09) | (0.54) |
Interest Coverage |
(1.85) | 66.45 | 38.65 |
| (0.86%) | (218.63%) | 0.00% | |
| (0.30%) | 23.43% | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(0.51%) | (110.90%) | (44.63%) |
Average Days of Receivables |
15.30 | 23.23 | 75.04 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
61.86% | 52.59% | 52.73% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 |
Graham Number |
— | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.09) | 0.01 | 0.01 |
Cash per Share |
0.40 | 0.18 | 0.14 |
Shareholders Equity per Share |
0.32 | 0.00 | (0.07) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.32 | 0.00 | (0.07) |
Free Cash Flow |
(1.52) | 0.14 | 0.08 |
Working Capital |
3.84 | (1.58) | (2.21) |
Capital Expenditures |
(0.31) | (0.29) | (0.21) |
Net Current Asset Value |
3.49 | (1.94) | (2.36) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.05 | 0.04 |
| Other line items | |||
Depreciation/Fixed assets |
0.36 | 0.53 | 0.83 |
Cash ROIC |
(12.81%) | 4.29% | 5.98% |
Accounts Receivable Turnover |
16.10 | 7.62 | 0.00 |
Accounts Payable Turnover |
0.11 | 0.04 | 0.00 |
Inventory Turnover |
1.34 | 0.56 | 0.00 |
Average Days of Payables |
4,306.38 | 5,804.68 | 14,574.16 |
Days of Inventory on Hand |
265.45 | 631.10 | 910.89 |
Revenue per Share |
0.30 | 0.41 | 0.39 |
Operating CF per Share |
(0.08) | 0.03 | 0.02 |
Capex per Share |
(0.02) | (0.02) | (0.01) |
Average Receivables |
0.30 | 0.82 | — |
Average Payables |
0.33 | 0.35 | — |
Average Inventory |
0.03 | 0.03 | — |
Average Assets |
7.61 | 5.12 | — |
Average Common Equity |
2.62 | (0.55) | — |
Columns are period end dates · fundamentals updated 12 Oct 2026